These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16672546)

  • 21. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients.
    Millon L; Drobacheff C; Piarroux R; Monod M; Reboux G; Laurent R; Meillet D
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):137-44. PubMed ID: 11242180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal IgA Prevents Commensal
    Millet N; Solis NV; Swidergall M
    Front Immunol; 2020; 11():555363. PubMed ID: 33193324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.
    Salvatori O; Puri S; Tati S; Edgerton M
    J Dent Res; 2016 Apr; 95(4):365-71. PubMed ID: 26747422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oropharyngeal Candida colonization in human immunodeficiency virus infected patients.
    Li X; Lei L; Tan D; Jiang L; Zeng X; Dan H; Liao G; Chen Q
    APMIS; 2013 May; 121(5):375-402. PubMed ID: 23030258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?
    Cutler CW; Jotwani R
    Adv Dent Res; 2006 Apr; 19(1):49-51. PubMed ID: 16672549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.
    Wozniak KL; Leigh JE; Hager S; Swoboda RK; Fidel PL
    J Infect Dis; 2002 May; 185(9):1269-76. PubMed ID: 12001044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.
    Wahl SM; Redford M; Christensen S; Mack W; Cohn J; Janoff EN; Mestecky J; Jenson HB; Navazesh M; Cohen M; Reichelderfer P; Kovacs A;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):401-11. PubMed ID: 21239996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral epithelial cells and their interactions with HIV-1.
    Moyes DL; Islam A; Kohli A; Naglik JR
    Oral Dis; 2016 Apr; 22 Suppl 1():66-72. PubMed ID: 26879550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress towards an AIDS mucosal vaccine: an overview.
    Yuki Y; Nochi T; Kiyono H
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.
    Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML
    J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Mucosal Epithelial Cells.
    Groeger S; Meyle J
    Front Immunol; 2019; 10():208. PubMed ID: 30837987
    [No Abstract]   [Full Text] [Related]  

  • 34. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genital and oral mucosal immune response against HIV-1 in exposed uninfected individuals.
    Hasselrot K
    Crit Rev Immunol; 2009; 29(5):369-77. PubMed ID: 20001886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
    Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
    AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral mucosal Langerhans' cells as target, effector and vector in HIV infection.
    Chou LL; Epstein J; Cassol SA; West DM; He W; Firth JD
    J Oral Pathol Med; 2000 Sep; 29(8):394-402. PubMed ID: 10972348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity.
    Opstad NL; Daley CL; Thurn JR; Rubins JB; Merrifield C; Hopewell PC; Janoff EN
    J Infect Dis; 1995 Aug; 172(2):566-70. PubMed ID: 7622907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pleiotropic role of vitamin A in regulating mucosal immunity.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):71-89. PubMed ID: 26141028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.